维百奥生物代理serox品牌全系列产品
Serox GmbH成立于20006年，专注于配体肽的研发，现已成为一家专门生产高品质肽的制造商。Serox凭借深厚的专业知识、先进的设施以及严格的质量控制流程，确保所生产的每一种肽都符合最高的行业标准，为客户提供关键的研发工作支持。作为客户成功的合作伙伴，Serox提供全面的肽合成服务，从定制设计到大规模生产，能够根据客户的独特需求量身定制解决方案。Serox公司产品线包括新型肽配体和定制肽。Serox 产品应用于：
● 蛋白质纯化：常用于纯化对特定肽具有已知结合亲和力的蛋白质或酶。
● 受体研究：用于分离与肽配体结合的特定受体蛋白。
● 蛋白质 - 蛋白质相互作用研究：通过固定与目标蛋白质特异性相互作用的肽配体来帮助识别结合伙伴。
● 肽筛选：用于药物发现，识别可能与特定靶标结合的潜在肽配体。
▍serox公司技术服务
● 肽配体亲和色谱（PLAC）：一种专门技术，利用蛋白质、肽或其他生物分子与特定肽配体的结合亲和力来分离或纯化蛋白质、肽或其他生物分子。该方法中，色谱柱填充有附有特定肽配体的基质，通过肽配体与其相应靶蛋白或分子之间的高亲和力结合相互作用，实现选择性纯化。
● 定制肽：致力于以精确和可靠的方式提供最高质量的肽。受监管的合成工艺和严格的质量控制，确保每个订单的一致性、纯度和性能。能够定制序列、全面修改，拥有灵活的数量和形式以及有竞争力的价格。其多肽可保证高达>98%的纯度。
▍serox部分产品列表
| 品名 | 货号 | Solubility | Purity |
| (3,5-Difluorophenylacetyl)-Ala-Phg-Obut | 2542551 | DMSO (10 mM) | ≧99.0% (HPLC) |
| (Z-Leu-Leu-NHCH₂)₂CO | 2542733 | DMSO (10 mM) | ≧99.0% (HPLC) |
| [Arg⁸]-Vasopressin | 2542618 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Arg⁸]-Vasotocin | 2542692 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Asu ¹·⁶ ]-Oxytocin | 2542583 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Asu¹·⁶,Arg⁸]-Vasopressin | 2542584 | H2O (0.1 mM) | ≧97.0% (HPLC) |
| [Asu¹·⁶,Arg⁸]-Vasotocin | 2542585 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [D-Ala²,D-Leu⁵]-Enkephalin | 2542641 | 0.1% AcOH (1 mM) | ≧99.0% (HPLC) |
| [D-Ala²,Met⁵]-Enkephalin | 2542642 | H2O (1 mM) | ≧98.0% (HPLC) |
| [D-Ala²,Met⁵]-Enkephalinamide | 2542643 | H2O (1 mM) | ≧98.0% (HPLC) |
| [D-Arg¹,D-Pro²,D-Trp⁷·⁹,Leu¹¹]-Substance P | 2542678 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| [D-Arg¹,D-Trp⁷·⁹,Leu¹¹]-Substance P [Spantide] | 2542679 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| [D-Pro²,D-Trp⁷’⁹]-Substance P | 2542639 | H2O (0.1 mM) | ≧97.0% (HPLC) |
| [D-Pro²,D-Trp⁷’⁹]-Substance P (4-11) | 2542640 | 1% AcOH (0.1 mM) | ≧98.0% (HPLC) |
| [D-Trp⁸]-Somatostatin | 2542630 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Hyp³]-Bradykinin | 2542693 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Met(O)¹²]-ANP (Human, 1-28) | 2542659 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| [Pmp¹,Tyr(Me)²]-Arg⁸-Vasopressin | 2542701 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Pyr³³]-Pancreastatin (Porcine, 33-49) | 2542688 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Pyr³³]-Pancreastatin (Porcine, 33-49) Antiserum | 2542962 | ||
| [Sar¹,Ala⁸]-Angiotensin II | 2542591 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Sar¹,Ile⁸]-Angiotensin II | 2542579 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Sar¹,Val⁵,Ala⁸]-Angiotensin II | 2542610 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Thi⁵·⁸,D-Phe⁷]-Bradykinin | 2542680 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Tyr¹]-Somatostatin | 2542593 | H2O (0.1 mM) | ≧97.0% (HPLC) |
| [Tyr³⁴]-Parathyroid Hormone (Bovine, 1-34 Amide) | 2542684 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| [Tyr³⁴]-Parathyroid Hormone (Bovine, 7-34 Amide) | 2542687 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| [Tyr⁸]-Bradykinin | 2542611 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Tyr⁸]-Substance P | 2542602 | H2O (0.1 mM) | ≧97.0% (HPLC) |
| [Val⁵]-Angiotensin I (Bovine) | 2542609 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| [Val⁵]-Angiotensin II | 2542590 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| Ac-Ile-Glu-Thr-Asp-AMC (Ac-IETD-AMC) | 2542886 | DMSO (10 mM) | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Leu-Glu-His-Asp-AMC (Ac-LEHD-AMC) | 2542888 | DMSO (10 mM) | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Lys-Val-Pro-Leu-ACC (Ac-KVPL-ACC) | 2542917 | DMSO (10 mM) | ≧98.0% (HPLC) |
| Ac-Lys-Val-Pro-Leu-CH₂Cl | 2542736 | H2O (10 mM) | ≧95.0% (HPLC) |
| Ac-Thz-Tle-Leu-Gln-AMC | 2542923 | DMSO (5 mM) | ≧98.0% (HPLC) |
| Ac-Trp-Glu-His-Asp-AMC (Ac-WEHD-AMC) | 2542884 | DMSO (10 mM) | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Tyr-Val-Ala-Asp-AMC | 2542870 | DMSO (10 mM) | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Val-Glu-Ile-Asp-AMC (Ac-VEID-AMC) | 2542880 | DMSO (10 mM) | ≧98.0% (HPLC), AMC≦0.1% |
| Ac-Val-Glu-Ile-Asp-H (aldehyde) | 2542722 | DMSO (10 mM) | ≧90.0% (HPLC) |
| ACTH (Human, 1-24) | 2542634 | H2O (0.1 mM) | ≧98.0% (HPLC) |
| Adjuvant Peptide | 2542589 | H2O (1 mM) | TLC single spot |
| Angiotensin I (Human) | 2542573 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| Angiotensin II (Human) | 2542570 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| Angiotensin III (Human) | 2542586 | H2O (0.1 mM) | ≧99.0% (HPLC) |
| ANP (Human, 1-28) | 2542650 | H2O (0.1 mM) | ≧98.0% (HPLC) |
